Autophagic Flux Bottlenecks in Neurodegenerative Disease: From Cell-Specific Failure to Defect-Directed Therapy

Autophagic dysfunction is a recurrent feature of neurodegenerative disease, but increased pathway activity does not necessarily indicate effective cargo clearance. This review examines autophagic flux as a multistep quality-control process in which cargo recognition, autophagosome formation, intracellular transport, lysosomal fusion, degradation, and metabolite recovery must remain functionally coupled. We discuss how bottlenecks at different stages generate distinct consequences across neurons, microglia, astrocytes, oligodendrocyte-lineage cells, and neural stem or progenitor cells, and compare disease-specific patterns in Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis/frontotemporal dementia, Huntington’s disease, and multiple sclerosis. These disorders exhibit overlapping but context-dependent autophagy–lysosomal defects, including impaired cargo recognition, mitochondrial turnover, autophagosome transport, lysosomal degradation, and cell-specific cargo processing. These mechanistic differences support defect-directed therapeutic strategies, although evidence that correcting individual bottlenecks restores autophagic flux and improves clinical outcomes remains limited. Upstream induction may be ineffective when downstream transport, fusion, or lysosomal degradation is impaired. Therapeutic strategies should therefore be evaluated using mechanism-appropriate measures of target engagement and downstream cargo degradation. Defining autophagic flux at cell- and compartment-specific resolution may help distinguish productive clearance from nonspecific pathway activation across disease stages, genotypes, and clinically distinct patient populations.

Authors

Institutions

Publication Details

Journal
Current Issues in Molecular Biology
Published
2026-11-12
DOI
https://doi.org/10.3390/cimb48111204
Primary Topic
Autophagy in Disease and Therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Autophagic Flux Bottlenecks in Neurodegenerative Disease: From Cell-Specific Failure to Defect-Directed Therapy

Tripti Nair, Prince Kumar Singh, Saurabh Shrivastva, Kamini Shivhare
Current Issues in Molecular Biology
Autophagy in Disease and Therapy
article

Autophagic Flux Bottlenecks in Neurodegenerative Disease: From Cell-Specific Failure to Defect-Directed Therapy

Tripti Nair, Prince Kumar Singh, Saurabh Shrivastva, Kamini Shivhare
article en

Abstract

Autophagic dysfunction is a recurrent feature of neurodegenerative disease, but increased pathway activity does not necessarily indicate effective cargo clearance. This review examines autophagic flux as a multistep quality-control process in which cargo recognition, autophagosome formation, intracellular transport, lysosomal fusion, degradation, and metabolite recovery must remain functionally coupled. We discuss how bottlenecks at different stages generate distinct consequences across neurons, microglia, astrocytes, oligodendrocyte-lineage cells, and neural stem or progenitor cells, and compare disease-specific patterns in Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis/frontotemporal dementia, Huntington’s disease, and multiple sclerosis. These disorders exhibit overlapping but context-dependent autophagy–lysosomal defects, including impaired cargo recognition, mitochondrial turnover, autophagosome transport, lysosomal degradation, and cell-specific cargo processing. These mechanistic differences support defect-directed therapeutic strategies, although evidence that correcting individual bottlenecks restores autophagic flux and improves clinical outcomes remains limited. Upstream induction may be ineffective when downstream transport, fusion, or lysosomal degradation is impaired. Therapeutic strategies should therefore be evaluated using mechanism-appropriate measures of target engagement and downstream cargo degradation. Defining autophagic flux at cell- and compartment-specific resolution may help distinguish productive clearance from nonspecific pathway activation across disease stages, genotypes, and clinically distinct patient populations.

Current Issues in Molecular BiologyVol. 48(11)
University of Southern California (US), Era's Lucknow Medical College and Hospital (IN), Indian Institute of Technology Delhi (IN), University of California, Berkeley (US)
Good health and well-being
Autophagy in Disease and Therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon